Form 8-K - Current report:
SEC Accession No. 0001559053-24-000028
Filing Date
2024-09-27
Accepted
2024-09-27 16:13:21
Documents
15
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K prta-20240923.htm   iXBRL 8-K 32821
2 EXHIBIT 99.1 PRESS RELEASE cmoandcdochanges_pressrele.htm EX-99.1 14175
6 GRAPHIC prtalogo.jpg GRAPHIC 24834
  Complete submission text file 0001559053-24-000028.txt   216799

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20240923.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20240923_lab.xml EX-101.LAB 23251
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20240923_pre.xml EX-101.PRE 13538
17 EXTRACTED XBRL INSTANCE DOCUMENT prta-20240923_htm.xml XML 2933
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 241335023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)